New drug candidate found to be highly effective in treating rare sight-threatening eye infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human

September 4, 2023

NS Pharma scores breakthrough therapy status for DMD therapy – Pharmaceutical Technology

Duchenne Muscular Dystrophy is one of the more prevalent genetic conditions – it affects 1 in every 3,500 male births worldwide. Image credit: Shutterstock/ChiccoDodiFC The

July 28, 2023

Diving Into Exciting Emerging Sectors With Cody Shandraw

The Dales Report brings you another psychedelic exclusive. Today we talk to entrepreneur Cody Shandraw, Managing Partner at Ambria Capital & Phyto Partners IV, about

September 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.